Our data now suggest that engagement of CXCL12–CXCR4 signaling during EPC–SMC interaction critically modulates SMC behavior and may thus confer alteration in lipid-induced atherosclerosis and postinjury vascular remodeling. Here, CXCL12 is linked to atherosclerosis.